These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1865415)

  • 21. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
    Amasaki Y; Sagawa A; Atsumi T; Jodo S; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S; Kobayashi H
    Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antiarthritic compounds on type II collagen-induced arthritis in rats.
    Probert AW; Schrier DJ; Gilbertsen RB
    Arch Int Pharmacodyn Ther; 1984 May; 269(1):167-76. PubMed ID: 6466005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of bucillamine and N-acetyl-L-cysteine on cytokine production and collagen-induced arthritis (CIA).
    Tsuji F; Miyake Y; Aono H; Kawashima Y; Mita S
    Clin Exp Immunol; 1999 Jan; 115(1):26-31. PubMed ID: 9933417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of combination glycyrrhiizin and triptolide on TNF-alpha and IL-10 in serum of collagen induced arthritis rats].
    Zhang WD; Lu C; Zhao HY; Chen SL; Yang DJ; Lu AP
    Zhongguo Zhong Yao Za Zhi; 2007 Mar; 32(5):414-7. PubMed ID: 17511148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition by Artocarpus tonkinensis of the development of collagen-induced arthritis in rats.
    Ngoc DD; Catrina AI; Lundberg K; Harris HE; Ha NT; Anh PT; Larsson P
    Scand J Immunol; 2005 Mar; 61(3):234-41. PubMed ID: 15787740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the effects of pharmacological agents on antigen-induced arthritis in BALB/c mice.
    Crossley MJ; Spowage M; Hunneyball IM
    Drugs Exp Clin Res; 1987; 13(5):273-7. PubMed ID: 2890505
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive effects of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice.
    Shin SS; Jin M; Jung HJ; Kim B; Jeon H; Choi JJ; Kim JM; Cho BW; Chung SH; Lee YW; Song YW; Kim S
    Rheumatology (Oxford); 2003 May; 42(5):665-72. PubMed ID: 12709543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects and mechanisms of glucosides of chaenomeles speciosa on collagen-induced arthritis in rats.
    Chen Q; Wei W
    Int Immunopharmacol; 2003 Apr; 3(4):593-608. PubMed ID: 12689663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects and mechanisms of total glucosides of paeony on synoviocytes activities in rat collagen-induced arthritis.
    Chang Y; Wei W; Zhang L; Xu HM
    J Ethnopharmacol; 2009 Jan; 121(1):43-8. PubMed ID: 18977427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro production of collagen by synovial fibroblasts from D-penicillamine-treated arthritic rabbits.
    Brisset M; Pujol JP; Penfornis H; Farjanel J; Rattner A; Bocquet J; Béliard R; Loyau G
    Int J Tissue React; 1986; 8(4):271-8. PubMed ID: 3017876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological studies on N-(2-mercapto-2-methylpropanoyl)-L-cysteine(SA96). IV. Effects of SA96 and its main metabolite, SA679, on denaturation of human gamma-globulin and adjuvant arthritis in rats].
    Yamauchi H; Hayashi M; Kasamatsu S; Suda H; Nakata K; Sasano M; Iso T
    Nihon Yakurigaku Zasshi; 1985 Apr; 85(4):275-82. PubMed ID: 2408978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis.
    Matsuno H; Kitano T; Matsushita I; Tsuji H; Ochiai H
    Drugs Exp Clin Res; 1993; 19(5):205-11. PubMed ID: 8174492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic effects of glucosides of Cheanomeles speciosa on collagen-induced arthritis in mice.
    Zhang LL; Wei W; Yan SX; Hu XY; Sun WY
    Acta Pharmacol Sin; 2004 Nov; 25(11):1495-501. PubMed ID: 15525473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment].
    Negishi M; Yamazaki J; Hosaka M; Iwabuchi H; Matsuda A; Kanemitsu H; Hiramatsu K; Kaga S; Hashimoto M; Kasama T
    Ryumachi; 1994 Jun; 34(3):651-5. PubMed ID: 8052932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course of bucillamine-induced nephropathy in patients with rheumatoid arthritis.
    Obayashi M; Uzu T; Harada T; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Dec; 7(4):275-8. PubMed ID: 14712356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental arthropathy induced in rhesus monkeys (Macaca mulatta) by intradermal immunization with native bovine type II collagen.
    Rubin AS; Healy CT; Martin LN; Baskin GB; Roberts ED
    Lab Invest; 1987 Nov; 57(5):524-34. PubMed ID: 3682764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
    Kawano M; Nomura H; Iwainaka Y; Nakashima A; Koni I; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of KE-758; an active metabolite of the new anti-rheumatic drug KE-298, D-penicillamine, bucillamine and auranofin on the proliferation of murine lymphocytes, and the production of nitric oxide by murine macrophages.
    Inoue T; Takeshita K; Fukushima K
    Int Immunopharmacol; 2001 May; 1(5):833-42. PubMed ID: 11379039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of bucillamine on the rat trinitrobenzene sulfonic acid induced model of colitis.
    Kitano A; Oshitani N; Okabe H; Hara J; Suzuki N; Aoki T; Adachi K; Watanabe Y; Yasuda K; Tabata A; Obayashi M; Nakamura S; Obata A; Matsumoto T; Okawa K; Kobayashi K
    Inflamm Res; 1996 Oct; 45(10):491-3. PubMed ID: 8912012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of mitogen-induced response of human peripheral blood mononuclear cells by bucillamine, a new antirheumatic sulfhydryl drug.
    Akamatsu T; Matsubara T; Saegusa Y; Mizuno K
    Rheumatol Int; 1994; 13(5):197-201. PubMed ID: 8202663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.